Wednesday, 4 December 2024
  
Login

Australia's most trusted
source of pharma news

Wednesday, 04 December 2024
News

Ex-Novartis boss shines as CEO

Posted 23 May 2024 AM

In less than five months at the helm of Starpharma, Cheryl Maley, has established a pathway to increase the company's revenue by "accelerating commercial opportunities" and "building stronger brands" for its existing products.

The Melbourne-based pharma is the only company to have commercialised dendrimer-based products, which includes antiviral nasal spray Viraleze and bacterial vaginosis treatment VivaGel, both based on SPL7013, a novel dendrimer with antimicrobial properties. 

To see the whole article, please login

Popular

Four PBS listings wrap up 2024
Which drugs made the PBAC's cut?
March agenda in disappearing act
Five bumped drugs reinstated
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home